Skip to main content
PGNY
NASDAQ Industrial Applications And Services

Progyny Reports Strong Q1 Results, Completes $200M Share Buyback, and Issues Positive 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$21.859
Mkt Cap
$1.501B
52W Low
$16.1
52W High
$28.75
52W Position info
36% above low
Off High info
24% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

PGNY sits 36% above its 52-week low of $16.1.

Summary

Progyny announced strong first-quarter 2026 financial results, including significant net income growth, and completed its $200 million share repurchase program, while also issuing positive guidance for the second quarter and full year 2026.


Key Events · Earnings and Guidance · PGNY

  • Strong Q1 2026 Financial Performance

    Progyny reported first-quarter 2026 revenue of $328.5 million, a 1.4% increase year-over-year (12.2% excluding a former large client). Net income significantly increased to $24.2 million, or $0.29 per diluted share, compared to $15.1 million, or $0.17 per diluted share, in the prior year period.

  • Completion of Share Repurchase Program

    The company completed its November 2025 share repurchase program, having bought back 5.5 million shares for $116.4 million during Q1 2026. Cumulatively, 8.8 million shares were repurchased under the $200 million authorization, and the Board is now evaluating options for a new program.

  • Positive Q2 and Full Year 2026 Guidance

    Progyny provided Q2 2026 revenue guidance of $342.0 million to $355.0 million and full-year 2026 revenue guidance of $1.365 billion to $1.405 billion. The company also projected full-year diluted EPS of $1.23 to $1.34 and Adjusted EBITDA of $232.0 million to $244.0 million.


Analysis · PGNY · Industrial Applications And Services

Progyny's first-quarter results demonstrate solid operational performance, with significant growth in net income and an expanded gross margin. The completion of the $200 million share repurchase program, with a substantial $116.4 million executed in Q1, signals a strong commitment to shareholder returns. The company's proactive evaluation of a new repurchase program further reinforces this positive capital allocation strategy. While Q2 revenue guidance was previously reported, the comprehensive full-year outlook and detailed Q1 results provide a clear picture of the company's financial health and future expectations, making this a strong positive signal for investors.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PGNY was trading at $21.86 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $16.10 to $28.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PGNY - Latest Insights

PGNY
Nov 05, 2026, 4:27 PM EST
Filing Type: 144
Importance Score:
7
Price at Filing: $34.37
Real-time Price: $36.86 info
Change: +$2.49 (+7%) info
Market Cap: $2.611B info
PGNY
Nov 05, 2026, 8:56 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $30.60
Real-time Price: $36.86 info
Change: +$6.26 (+20%) info
Market Cap: $2.611B info
PGNY
Nov 04, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.10
Real-time Price: $36.86 info
Change: +$6.76 (+22%) info
Market Cap: $2.611B info
PGNY
Nov 04, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $30.04
Real-time Price: $36.86 info
Change: +$6.82 (+23%) info
Market Cap: $2.611B info
PGNY
Aug 07, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $26.24
Real-time Price: $36.86 info
Change: +$10.62 (+40%) info
Market Cap: $2.611B info